Screener
Xeris Biopharma Holdings, Inc. XERS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s shares (diluted)?
- Xeris Biopharma Holdings, Inc. (XERS) reported shares (diluted) of 172.8M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s shares (diluted) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s shares (diluted) increased by 8.4% year-over-year, from 159.5M to 172.8M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s shares (diluted) has grown at a 24.8% compound annual growth rate (CAGR), from 273.1M to 662.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Xeris Biopharma Holdings, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude